Cargando…

Effects of Bifidobacterium BL21 and Lacticaseibacillus LRa05 on gut microbiota in type 2 diabetes mellitus mice

Gut dysbiosis causes damage to the intestinal barrier and is associated with type 2 diabetes mellitus (T2DM). We tested the potential protective effects of probiotic BL21 and LRa05 on gut microbiota in type 2 diabetes mellitus mice and determined whether these effects were related to the modulation...

Descripción completa

Detalles Bibliográficos
Autores principales: Gai, Zhonghui, Liao, Wenyan, Huang, Yue, Dong, Yao, Feng, Huafeng, Han, Mei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10505128/
https://www.ncbi.nlm.nih.gov/pubmed/37716924
http://dx.doi.org/10.1186/s13568-023-01603-1
_version_ 1785106853746704384
author Gai, Zhonghui
Liao, Wenyan
Huang, Yue
Dong, Yao
Feng, Huafeng
Han, Mei
author_facet Gai, Zhonghui
Liao, Wenyan
Huang, Yue
Dong, Yao
Feng, Huafeng
Han, Mei
author_sort Gai, Zhonghui
collection PubMed
description Gut dysbiosis causes damage to the intestinal barrier and is associated with type 2 diabetes mellitus (T2DM). We tested the potential protective effects of probiotic BL21 and LRa05 on gut microbiota in type 2 diabetes mellitus mice and determined whether these effects were related to the modulation of gut microbiota.Thirty specific pathogen-free C57BL/6J mice were randomly allocated to three groups—the (CTL) control group, HFD/STZ model (T2DM) group, and HFD/STZ-probiotic intervention (PRO) group—and intragastrically administered strains BL21 and LRa05 for 11 weeks. The administration of strains BL21 and LRa05 significantly regulated blood glucose levels, accompanied by ameliorated oxidative stress in mice. The BL21/LRa05-treated mice were protected from liver, cecal, and colon damage. Microbiota analysis showed that the cecal and fecal microbiota of the mice presented significantly different spatial distributions from one another. Principal coordinate analysis results indicated that both T2DM and the BL21/LRa05 intervention had significant effects on the cecal contents and fecal microbiota structure. In terms of the fecal microbiota, an abundance of Akkermansia and Anaeroplasma was noted in the PRO group. In terms of the cecal content microbiota, enrichment of Akkermansia, Desulfovibrio, Bifidobacterium, Lactobacillus, and Limosilactobacillus was noted in the PRO group. The probiotics BL21 and LRa05 prevent or ameliorate T2DM by regulating the intestinal flora and reducing inflammation and oxidative stress. Our results suggest that BL21 and LRa05 colonize in the cecum. Thus, BL21/LRa05 combined with probiotics having a strong ability to colonize in the colon may achieve better therapeutic effects in T2DM. Our study illustrated the feasibility and benefits of the combined use of probiotics and implied the importance of intervening at multiple intestinal sites in T2DM mice. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13568-023-01603-1.
format Online
Article
Text
id pubmed-10505128
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-105051282023-09-18 Effects of Bifidobacterium BL21 and Lacticaseibacillus LRa05 on gut microbiota in type 2 diabetes mellitus mice Gai, Zhonghui Liao, Wenyan Huang, Yue Dong, Yao Feng, Huafeng Han, Mei AMB Express Original Article Gut dysbiosis causes damage to the intestinal barrier and is associated with type 2 diabetes mellitus (T2DM). We tested the potential protective effects of probiotic BL21 and LRa05 on gut microbiota in type 2 diabetes mellitus mice and determined whether these effects were related to the modulation of gut microbiota.Thirty specific pathogen-free C57BL/6J mice were randomly allocated to three groups—the (CTL) control group, HFD/STZ model (T2DM) group, and HFD/STZ-probiotic intervention (PRO) group—and intragastrically administered strains BL21 and LRa05 for 11 weeks. The administration of strains BL21 and LRa05 significantly regulated blood glucose levels, accompanied by ameliorated oxidative stress in mice. The BL21/LRa05-treated mice were protected from liver, cecal, and colon damage. Microbiota analysis showed that the cecal and fecal microbiota of the mice presented significantly different spatial distributions from one another. Principal coordinate analysis results indicated that both T2DM and the BL21/LRa05 intervention had significant effects on the cecal contents and fecal microbiota structure. In terms of the fecal microbiota, an abundance of Akkermansia and Anaeroplasma was noted in the PRO group. In terms of the cecal content microbiota, enrichment of Akkermansia, Desulfovibrio, Bifidobacterium, Lactobacillus, and Limosilactobacillus was noted in the PRO group. The probiotics BL21 and LRa05 prevent or ameliorate T2DM by regulating the intestinal flora and reducing inflammation and oxidative stress. Our results suggest that BL21 and LRa05 colonize in the cecum. Thus, BL21/LRa05 combined with probiotics having a strong ability to colonize in the colon may achieve better therapeutic effects in T2DM. Our study illustrated the feasibility and benefits of the combined use of probiotics and implied the importance of intervening at multiple intestinal sites in T2DM mice. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13568-023-01603-1. Springer Berlin Heidelberg 2023-09-16 /pmc/articles/PMC10505128/ /pubmed/37716924 http://dx.doi.org/10.1186/s13568-023-01603-1 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Original Article
Gai, Zhonghui
Liao, Wenyan
Huang, Yue
Dong, Yao
Feng, Huafeng
Han, Mei
Effects of Bifidobacterium BL21 and Lacticaseibacillus LRa05 on gut microbiota in type 2 diabetes mellitus mice
title Effects of Bifidobacterium BL21 and Lacticaseibacillus LRa05 on gut microbiota in type 2 diabetes mellitus mice
title_full Effects of Bifidobacterium BL21 and Lacticaseibacillus LRa05 on gut microbiota in type 2 diabetes mellitus mice
title_fullStr Effects of Bifidobacterium BL21 and Lacticaseibacillus LRa05 on gut microbiota in type 2 diabetes mellitus mice
title_full_unstemmed Effects of Bifidobacterium BL21 and Lacticaseibacillus LRa05 on gut microbiota in type 2 diabetes mellitus mice
title_short Effects of Bifidobacterium BL21 and Lacticaseibacillus LRa05 on gut microbiota in type 2 diabetes mellitus mice
title_sort effects of bifidobacterium bl21 and lacticaseibacillus lra05 on gut microbiota in type 2 diabetes mellitus mice
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10505128/
https://www.ncbi.nlm.nih.gov/pubmed/37716924
http://dx.doi.org/10.1186/s13568-023-01603-1
work_keys_str_mv AT gaizhonghui effectsofbifidobacteriumbl21andlacticaseibacilluslra05ongutmicrobiotaintype2diabetesmellitusmice
AT liaowenyan effectsofbifidobacteriumbl21andlacticaseibacilluslra05ongutmicrobiotaintype2diabetesmellitusmice
AT huangyue effectsofbifidobacteriumbl21andlacticaseibacilluslra05ongutmicrobiotaintype2diabetesmellitusmice
AT dongyao effectsofbifidobacteriumbl21andlacticaseibacilluslra05ongutmicrobiotaintype2diabetesmellitusmice
AT fenghuafeng effectsofbifidobacteriumbl21andlacticaseibacilluslra05ongutmicrobiotaintype2diabetesmellitusmice
AT hanmei effectsofbifidobacteriumbl21andlacticaseibacilluslra05ongutmicrobiotaintype2diabetesmellitusmice